A systematic review of interventions to reduce hospitalisation in Parkinson's disease

被引:25
作者
Muzerengi, S. [1 ,2 ]
Herd, C. [3 ]
Rick, C. [3 ]
Clarke, C. E. [1 ,3 ,4 ]
机构
[1] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England
[2] Univ Hosp Birmingham Fdn Trust, Birmingham, W Midlands, England
[3] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
[4] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England
关键词
Parkinson's disease; Hospitalisation; Interventions; Randomised controlled trial; HEALTH-CARE UTILIZATION; EMERGENCY-ROOM VISITS; ADHERENCE; POPULATION; MEDICATION; OUTCOMES; BURDEN; ASSOCIATION; THERAPY; COSTS;
D O I
10.1016/j.parkreldis.2016.01.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The neurodegenerative process in Parkinson's disease (PD) results in a relentless progression of motor and non-motor symptoms. Affected individuals are frequently hospitalised for complications of the disease including falls, fractures, infections, and neuropsychiatric symptoms. When admitted to hospital, inpatient care is often suboptimal as it focusses on the primary cause of admission, and is associated with poor patient outcomes and significant healthcare costs. Aim: To review existing literature for evidence-based interventions aimed at reducing hospital admissions in PD. Methods: Electronic literature search in EMBASE, MEDLINE and CINAHL databases for studies evaluating interventions to reduce hospital admissions in PD. We included publications with full abstracts, published in the English language and addressing interventions to reduce hospital admissions in PD. Results: To date there are no randomised controlled trials addressing the topic. We identified nine relevant retrospective studies. Results from these studies suggest an association between frequent neurologist consultations, open access clinics, and medication compliance with a reduction in PD hospital admissions and emergency room visits. Conclusion: This systematic review highlights the lack of robust evidence for measures aimed at reducing hospital admissions in people with PD. Future prospective studies are required to evaluate the effectiveness of proposed interventions. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 30 条
[1]   Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease [J].
Caslake, Robert ;
Macleod, Angus ;
Ives, Natalie ;
Stowe, Rebecca ;
Counsell, Carl .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04)
[2]   Prevalence and Cost of Medication Nonadherence in Parkinson's Disease: Evidence from Administrative Claims Data [J].
Davis, Keith L. ;
Edin, Heather M. ;
Allen, Jeffery K. .
MOVEMENT DISORDERS, 2010, 25 (04) :474-480
[3]   The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinson's Disease A Retrospective Claims-Based Analysis [J].
Delea, Thomas E. ;
Thomas, Simu K. ;
Hagiwara, May .
CNS DRUGS, 2011, 25 (01) :53-66
[4]   Motor outcomes during hospitalization in Parkinson's disease patients: A prospective study [J].
Gerlach, Oliver H. H. ;
Broen, Martijn P. G. ;
Weber, Wim E. J. .
PARKINSONISM & RELATED DISORDERS, 2013, 19 (08) :737-741
[5]   Deterioration of Parkinson's disease during hospitalization: survey of 684 patients [J].
Gerlach, Oliver H. H. ;
Broen, Martijn P. G. ;
van Domburg, Peter H. M. F. ;
Vermeij, Ad J. ;
Weber, Wim E. J. .
BMC NEUROLOGY, 2012, 12
[6]  
Gibson PG, 2003, Cochrane Database Syst Rev, V2003
[7]   Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised [J].
Gray, Richard ;
Ives, Natalie ;
Rick, Caroline ;
Patel, Smitaa ;
Gray, Alastair ;
Jenkinson, Crispin ;
McIntosh, Emma ;
Wheatley, Keith ;
Williams, Adrian ;
Clarke, Carl E. ;
Sandercock, P. ;
Baigent, C. ;
Crome, P. ;
Williams, A. ;
Abbott, R. ;
Baker, M. ;
Castleton, B. ;
Clarke, C. E. ;
Counsell, C. ;
Deb, A. K. ;
Fairweather, S. ;
Fitzpatrick, R. ;
Gray, A. ;
Ives, N. ;
Jenkinson, C. ;
MacPhee, G. ;
Malone, T. ;
Mant, D. ;
McIntosh, E. ;
Ming, A. ;
Morrish, P. ;
Ohri, P. ;
Pearce, V. ;
Wood, B. ;
Worth, P. ;
Au, P. ;
Boodell, T. ;
Cheed, V. ;
Clarke, C. E. ;
Daniels, J. ;
Dowling, F. ;
Edmondson, A. ;
Gray, R. ;
Hawker, R. ;
Herd, C. ;
Hilken, N. ;
Ives, N. ;
Kaur, S. ;
Ottridge, R. ;
Patel, S. .
LANCET, 2014, 384 (9949) :1196-1205
[8]   Adherence to Antiparkinson Medication in a Multicenter European Study [J].
Grosset, Donald ;
Antonini, Angelo ;
Canesi, Margherita ;
Pezzoli, Gianni ;
Lees, Andrew ;
Shaw, Karen ;
Cubo, Esther ;
Martinez-Martin, Pablo ;
Rascol, Olivier ;
Negre-Pages, Laurence ;
Senard, Ana ;
Schwarz, Johannes ;
Strecker, Karl ;
Reichmann, Heinz ;
Storch, Alexander ;
Loehle, Matthias ;
Stocchi, Fabrizio ;
Grosset, Katherine .
MOVEMENT DISORDERS, 2009, 24 (06) :826-832
[9]   COMPARISON OF HOSPITALIZATIONS, EMERGENCY ROOM VISITS, FRACTURES, AND FALLS AMONG PARKINSON DISEASE PATIENTS WHO INITIATED THERAPY WITH SELEGILINE OR RASAGILINE: A RETROSPECTIVE STUDY [J].
Grubb, E. ;
Treglia, M. ;
Lage, M. ;
Castelli-Haley, J. .
VALUE IN HEALTH, 2013, 16 (03) :A105-A105
[10]  
GRUBB E, 2012, VALUE HEALTH, V15, pA558